Recent developments in gene therapy research in India
Author:
Funder
Vision Group on Science and Technology
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s12038-024-00423-0.pdf
Reference131 articles.
1. Anguela XM and High KA 2019 Entering the modern era of gene therapy. Annu. Rev. Med. 70 273–288
2. Appledorn DM, Patial Sonika, McBride Aaron, et al. 2008 Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. J. Immunol. 181 2134–2144
3. Arabi F, Mansouri V and Ahmadbeigi N 2022 Gene therapy clinical trials, where do we go? An overview. Biomed. Pharmacother. 153 113324
4. Arber W and Linn S 1969 DNA modification and restriction. Annu. Rev. Biochem. 38 467–500
5. Asokan A, Conway JC, Phillips JL, et al. 2010 Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle. Nat. Biotechnol. 28 79–82
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current status of research in rare genetic disorders and drug discovery in India;Journal of Biosciences;2024-02-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3